Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location
暂无分享,去创建一个
M. Ladd | H. Schlemmer | A. Unterberg | W. Wick | P. Bachert | M. Zaiss | A. Radbruch | M. Bendszus | S. Bickelhaupt | D. Paech | F. Sahm | C. Dreher | J. Windschuh | J. Meissner | P. Schuenke | Johanna Oberhollenzer | S. Regnery | J. Oberhollenzer | Patrick Schuenke
[1] Yuanyuan Wang,et al. Anatomic mapping of molecular subtypes in diffuse glioma , 2017, BMC Neurology.
[2] P. V. van Zijl,et al. Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRI , 2017, Magnetic resonance in medicine.
[3] Sebastian Bickelhaupt,et al. T1ρ-weighted Dynamic Glucose-enhanced MR Imaging in the Human Brain. , 2017, Radiology.
[4] T. Cloughesy,et al. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II–III diffuse gliomas , 2017, Journal of Neuro-Oncology.
[5] Aliasgar Moiyadi,et al. Subventricular zone involvement in Glioblastoma – A proteomic evaluation and clinicoradiological correlation , 2017, Scientific Reports.
[6] Peter Bachert,et al. Simultaneous mapping of water shift and B1(WASABI)—Application to field‐Inhomogeneity correction of CEST MRI data , 2017, Magnetic resonance in medicine.
[7] Daniel Paech,et al. Downfield‐NOE‐suppressed amide‐CEST‐MRI at 7 Tesla provides a unique contrast in human glioblastoma , 2017, Magnetic resonance in medicine.
[8] A. Kaye,et al. Frontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors , 2016, Journal of Clinical Neuroscience.
[9] A. Kaye,et al. IDH1 mutation may not be prognostically favorable in glioblastoma when controlled for tumor location: A case-control study , 2016, Journal of clinical neuroscience.
[10] Hye-Young Heo,et al. Whole‐brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low‐power steady‐state pulsed chemical exchange saturation transfer (CEST) imaging at 7T , 2016, Journal of magnetic resonance imaging : JMRI.
[11] Rebecca A. Ihrie,et al. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis , 2016, Journal of Neuro-Oncology.
[12] T. Jiang,et al. IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry , 2015, Oncotarget.
[13] Benjamin Schmitt,et al. Relaxation-compensated CEST-MRI of the human brain at 7T: Unbiased insight into NOE and amide signal changes in human glioblastoma , 2015, NeuroImage.
[14] Daniel Paech,et al. Correction of B1‐inhomogeneities for relaxation‐compensated CEST imaging at 7 T , 2015, NMR in biomedicine.
[15] Daniel Paech,et al. Nuclear Overhauser Enhancement Imaging of Glioblastoma at 7 Tesla: Region Specific Correlation with Apparent Diffusion Coefficient and Histology , 2015, PloS one.
[16] Peter Bachert,et al. A combined analytical solution for chemical exchange saturation transfer and semi‐solid magnetization transfer , 2015, NMR in biomedicine.
[17] Daniel Paech,et al. Nuclear Overhauser Enhancement Mediated Chemical Exchange Saturation Transfer Imaging at 7 Tesla in Glioblastoma Patients , 2014, PloS one.
[18] Lei Wang,et al. Anatomical specificity of O6-methylguanine DNA methyltransferase protein expression in glioblastomas , 2014, Journal of Neuro-Oncology.
[19] Koji Yamashita,et al. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. , 2014, Neuro-oncology.
[20] Peter Bachert,et al. Inverse Z‐spectrum analysis for spillover‐, MT‐, and T1‐corrected steady‐state pulsed CEST‐MRI – application to pH‐weighted MRI of acute stroke , 2014, NMR in biomedicine.
[21] Alexander Radbruch,et al. MR imaging of protein folding in vitro employing Nuclear‐Overhauser‐mediated saturation transfer , 2013, NMR in biomedicine.
[22] Lihua Chen,et al. The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis , 2013, PloS one.
[23] Richard A. E. Edden,et al. Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T , 2013, NeuroImage.
[24] Benjamin M Ellingson,et al. Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images. , 2013, Neuro-oncology.
[25] Klaus H. Maier-Hein,et al. The Medical Imaging Interaction Toolkit: challenges and advances , 2013, International Journal of Computer Assisted Radiology and Surgery.
[26] Tao Jin,et al. MR imaging of the amide‐proton transfer effect and the pH‐insensitive nuclear overhauser effect at 9.4 T , 2013, Magnetic resonance in medicine.
[27] S. Cha,et al. Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. , 2013, Neuro-oncology.
[28] T. Cloughesy,et al. Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma , 2012, American Journal of Neuroradiology.
[29] Robert J. Harris,et al. Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas , 2012, NeuroImage.
[30] Zhaoshi Jiang,et al. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Jinyuan Zhou,et al. Optimization of pulse train presaturation for CEST imaging in clinical scanners , 2011, Magnetic resonance in medicine.
[32] A. Olivi,et al. Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. , 2011, Journal of neurosurgery.
[33] Ru-Fang Yeh,et al. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. , 2010, Radiology.
[34] R. Stupp,et al. Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[35] Scott VandenBerg,et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. , 2007, Neuro-oncology.
[36] Maria Grazia Bruzzone,et al. Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged Survival , 2007, Clinical Cancer Research.
[37] Takeo Ishigaki,et al. Regional ADC values of the normal brain: differences due to age, gender, and laterality , 2002, European Radiology.
[38] Alan C. Evans,et al. Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. , 2001, Cerebral cortex.
[39] S. Coons,et al. Regional Heterogeneity in the Proliferative Activity of Human Gliomas as Measured by the Ki‐67 Labeling Index , 1993, Journal of neuropathology and experimental neurology.